News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
259,176 Results
Type
Article (6076)
Company Profile (56)
Press Release (253039)
Multimedia
Podcasts (19)
Webinars (8)
Section
Business (75135)
Career Advice (335)
Deals (14564)
Drug Delivery (28)
Drug Development (23375)
Employer Resources (34)
FDA (6631)
Job Trends (6253)
News (119740)
Policy (8540)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (640)
Accelerated approval (12)
Allergies (83)
Alliances (20958)
ALS (80)
Alzheimer's disease (604)
Antibody-drug conjugate (ADC) (132)
Approvals (6953)
Artificial intelligence (341)
Autoimmune disease (66)
Automation (31)
Bankruptcy (90)
Best Places to Work (5882)
BIOSECURE Act (7)
Biosimilars (84)
Biotechnology (41)
Bladder cancer (111)
Brain cancer (24)
Breast cancer (356)
Cancer (2522)
Cardiovascular disease (167)
Career advice (293)
Career pathing (11)
CAR-T (94)
CDC (4)
Cell therapy (309)
Cervical cancer (22)
Clinical research (22522)
Collaboration (988)
Compensation (287)
Complete response letters (14)
COVID-19 (799)
CRISPR (45)
C-suite (353)
Cystic fibrosis (55)
Data (3429)
Decentralized trials (2)
Denatured (5)
Depression (48)
Diabetes (225)
Diagnostics (3901)
Digital health (31)
Diversity (5)
Diversity, equity & inclusion (13)
Drug discovery (118)
Drug pricing (37)
Drug shortages (7)
Duchenne muscular dystrophy (85)
Earnings (38489)
Editorial (14)
Employer branding (1)
Employer resources (31)
Events (34505)
Executive appointments (445)
FDA (8599)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (2)
Frontotemporal dementia (9)
Funding (779)
Gene editing (83)
Generative AI (19)
Gene therapy (238)
GLP-1 (318)
Government (959)
Grass and pollen (4)
Guidances (319)
Healthcare (7674)
HIV (40)
Huntington's disease (17)
IgA nephropathy (39)
Immunology and inflammation (72)
Immuno-oncology (23)
Indications (63)
Infectious disease (922)
Inflammatory bowel disease (77)
Inflation Reduction Act (3)
Influenza (57)
Intellectual property (113)
Interviews (50)
IPO (7194)
IRA (7)
Job creations (674)
Job search strategy (228)
JPM (15)
Kidney cancer (8)
Labor market (35)
Layoffs (107)
Leadership (10)
Legal (1322)
Liver cancer (29)
Longevity (6)
Lung cancer (354)
Lymphoma (197)
Machine learning (24)
Management (13)
Manufacturing (439)
MASH (65)
Medical device (8195)
Medtech (8232)
Mergers & acquisitions (8057)
Metabolic disorders (502)
Multiple sclerosis (62)
NASH (3)
Neurodegenerative disease (134)
Neuropsychiatric disorders (30)
Neuroscience (1153)
NextGen: Class of 2026 (2685)
Non-profit (1105)
Now hiring (9)
Obesity (215)
Opinion (73)
Ovarian cancer (87)
Pain (128)
Pancreatic cancer (132)
Parkinson's disease (143)
Partnered (19)
Patents (224)
Patient recruitment (245)
Peanut (31)
People (16856)
Pharmaceutical (10)
Pharmacy benefit managers (10)
Phase 1 (6341)
Phase 2 (9989)
Phase 3 (8209)
Pipeline (3472)
Policy (42)
Postmarket research (622)
Preclinical (1993)
Press Release (19)
Prostate cancer (127)
Psychedelics (8)
Radiopharmaceuticals (116)
Rare diseases (345)
Real estate (1835)
Recruiting (10)
Regulatory (8294)
Reports (29)
Research institute (696)
Resumes & cover letters (53)
Rett syndrome (24)
RNA editing (5)
RSV (38)
Schizophrenia (71)
Series A (121)
Series B (107)
Service/supplier (6)
Sickle cell disease (31)
Special edition (12)
Spinal muscular atrophy (62)
Sponsored (26)
Startups (884)
State (2)
Stomach cancer (1)
Supply chain (62)
Tariffs (21)
The Weekly (14)
Vaccines (301)
Venture capital (18)
Weight loss (115)
Women's health (50)
Worklife (4)
Date
Today (38)
Last 7 days (295)
Last 30 days (1106)
Last 365 days (16034)
2026 (1550)
2025 (16367)
2024 (16820)
2023 (17771)
2022 (23790)
2021 (25258)
2020 (24814)
2019 (20128)
2018 (14540)
2017 (12421)
2016 (10930)
2015 (12512)
2014 (8890)
2013 (6994)
2012 (7560)
2011 (7521)
2010 (6290)
Location
Africa (176)
Alabama (42)
Alaska (2)
Arizona (108)
Arkansas (5)
Asia (12610)
Australia (1653)
California (6238)
Canada (1487)
China (462)
Colorado (294)
Connecticut (263)
Delaware (234)
Europe (33703)
Florida (861)
Georgia (241)
Hawaii (3)
Idaho (46)
Illinois (523)
India (46)
Indiana (385)
Iowa (10)
Japan (280)
Kansas (45)
Kentucky (14)
Louisiana (14)
Maine (53)
Maryland (603)
Massachusetts (4028)
Michigan (200)
Minnesota (415)
Mississippi (5)
Missouri (94)
Montana (19)
Nebraska (13)
Nevada (89)
New Hampshire (57)
New Jersey (1660)
New Mexico (17)
New York (1336)
North Carolina (822)
North Dakota (9)
Northern California (2988)
Ohio (186)
Oklahoma (10)
Oregon (21)
Pennsylvania (1082)
Puerto Rico (11)
Rhode Island (30)
South America (356)
South Carolina (54)
South Dakota (1)
Southern California (2466)
Tennessee (94)
Texas (1062)
United States (21449)
Utah (170)
Vermont (1)
Virginia (148)
Washington D.C. (33)
Washington State (464)
West Virginia (2)
Wisconsin (97)
Wyoming (1)
259,176 Results for "q2 solutions".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Immutep Quarterly Activities Report Q2 FY26
January 29, 2026
·
16 min read
Job Trends
Bonus Episode: Q2 2025 Job Market Update
In this bonus episode,
BioSpace’s
Vice President of Marketing Chantal Dresner and Careers Editor Angela Gabriel take a look at Q2 job market performance, layoffs and wider employment trends and policies impacting the biopharma workforce.
July 15, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update
February 1, 2026
·
12 min read
Press Releases
Biovica International AB - Q2 Interim report Aug - Oct 2025
December 18, 2025
·
7 min read
Job Trends
Report: U.S. Life Sciences Job Market Report Q2 2025
The life sciences job market continues to shift.
BioSpace
’s Q2 2025 U.S. Life Sciences Job Market Report is now available, offering exclusive insights into the latest hiring trends, layoffs, and workforce dynamics across the life sciences industry.
July 17, 2025
·
1 min read
·
BioSpace Insights
Press Releases
Spyre Therapeutics Poised for Transformational 2026 With Six Expected Proof-of-Concept Readouts Beginning in Q2
January 12, 2026
·
6 min read
Press Releases
MapLight Therapeutics Updates Expected Timing of Topline Results for Ongoing Phase 2 Studies to Q3 2026
January 9, 2026
·
3 min read
Press Releases
Dogwood Therapeutics Announces 50% Enrollment in Ongoing Halneuron® Phase 2b Trial, Top Line Results Anticipated in Q3 2026
February 2, 2026
·
5 min read
Press Releases
Piramal Pharma Limited Announces Results for Q2 and H1 FY26
November 6, 2025
·
7 min read
Press Releases
Aethlon Medical Announces Fiscal Q2 2025 Financial Results and Corporate Update
November 13, 2025
·
14 min read
1 of 25,918
Next
